PLAB vs ICHR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

PLAB

52.6
AI Score
VS
ICHR Wins

ICHR

55.4
AI Score

Investment Advisor Scores

PLAB

53score
Recommendation
HOLD

ICHR

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PLAB ICHR Winner
Forward P/E 13.2626 69.9301 PLAB
PEG Ratio 2.6419 0.9972 ICHR
Revenue Growth -0.5% 4.7% ICHR
Earnings Growth 270.5% -6.1% PLAB
Tradestie Score 52.6/100 55.4/100 ICHR
Profit Margin 18.5% -5.3% PLAB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PLAB 1M: +8.7% · 3M: -37.5% ICHR 1M: -18.3% · 3M: +24.5%

Current Technical Phase

PLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $31.36

ICHR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $80.23

Fundamentals Snapshot

Metric PLAB ICHR
Market Cap
Forward P/E 15.5 29.8
Trailing P/E 11.2
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.1%
Operating Margin 0.2% 0.0%
EPS 2.71 -1.48
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICHR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.